首页> 外国专利> REAGENT TESTING KIT FOR AIDED DIAGNOSIS OF PULMONARY ADENOCARCINOMA PATIENT

REAGENT TESTING KIT FOR AIDED DIAGNOSIS OF PULMONARY ADENOCARCINOMA PATIENT

机译:肺腺癌患者辅助诊断试剂盒

摘要

Disclosed is a reagent testing kit for aided diagnosis of a pulmonary adenocarcinoma patient. The reagent testing kit provided in the present invention comprises a product used for detecting protein marker IDH1, a product used for detecting protein marker CEF, a product used for detecting protein marker CA125, a product used for detecting protein marker CYFRA21-1, and a carrier describing the following function: formula I, where x1 represents the concentration of IDH1, x2 represents the concentration of CEA, x3 represents the concentration of CA125, and x4 represents the concentration of CYFRA21-1. Aided diagnosis of the pulmonary adenocarcinoma patient by employing the reagent testing kit provided in the present invention and following a corresponding diagnostic criterion provides the characteristics of high sensitivity and strong specificity, allows the reliability of a diagnosis result to be far greater than that of employing each of the individual protein markers for diagnosis, and has a significant value and application prospect in diagnosis and treatment of pulmonary adenocarcinoma.
机译:公开了一种用于辅助诊断肺腺癌患者的试剂测试试剂盒。本发明提供的试剂检测试剂盒包括用于检测蛋白质标记物IDH1的产品,用于检测蛋白质标记物CEF的产品,用于检测蛋白质标记物CA125的产品,用于检测蛋白质标记物CYFRA21-1的产品和载体,其描述以下功能:式I,其中x1代表IDH1的浓度,x2代表CEA的浓度,x3代表CA125的浓度,x4代表CYFRA21-1的浓度。通过采用本发明提供的试剂检测试剂盒并按照相应的诊断标准对肺腺癌患者进行辅助诊断,具有灵敏度高,特异性强的特点,使得诊断结果的可靠性远高于采用每种方法的诊断结果的可靠性。单个蛋白标志物的诊断,在肺腺癌的诊治中具有重要的价值和应用前景。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号